Search Within

GLUCAGON
Results 1 - 185 of 185
Glucagon and Glucagon-Like Peptide Receptors as Drug Targets

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 14
Page: 1731-1750
Authors: J. L. Estall and D. J. Drucker

The Design and Biological Activities of Glucagon Agonists and Antagonists,and their Use in Examining the Mechanisms of Glucose Action

Journal: Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
Volume: 1,Issue: 3
Page: 199-215
Authors: V. J. Hruby, J-M. Ahn and D. Trivedi

Therapeutic Potential of Coagonists of Glucagon and GLP-1

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 12,Issue: 2
Page: 126-133
Authors: Vishal J. Patel, Amit A. Joharapurkar, Samadhan G. Kshirsagar, Kartikkumar N. Patel, Gaurang B. Shah and Mukul R. Jain

Production and Purification of Recombinant Human Glucagon Overexpressed as Intein Fusion Protein in Escherichia coli

Journal: Protein & Peptide Letters
Volume: 13,Issue: 4
Page: 343-347
Authors: Roman S. Esipov, Vasily N. Stepanenko, Alexandr I. Gurevich, Larisa A. Chupova and Anatoly I. Miroshnikov

Glucagon and Cyclic AMP: Time to Turn the Page?

Journal: Current Diabetes Reviews
Volume: 8,Issue: 5
Page: 362-381
Authors: Robert L. Rodgers

Glucagon Like Peptide-1 and Atherosclerosis

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10,Issue: 4
Page: 309-318
Authors: Tomoya Mita and Hirotaka Watada

Circular Dichroism Reveals Sensitivity of Glucagon Solution Structure to Fluoroalcohols, pH and Ionic Strength

Journal: Protein & Peptide Letters
Volume: 15,Issue: 8
Page: 811-817
Authors: S. Guest, V. V. Ngo and M. A. Hefford

Developments of Glucagon Like Peptide-1 (GLP-1) and Long-acting Analogs in Clinical and Preclinical Studies for Treatment of Type 2 Diabetes

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 9
Page: 835-841
Authors: Yazhuo Li, Lida Tang and Min Gong

Glucagon-like Peptides, the Central Nervous System, and the Regulation of Energy Homeostasis

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 3,Issue: 2
Page: 73-80
Authors: Julie A. Lovshin and Daniel J. Drucker

Incretins Yesterday, Pleiotropic Gastrointestinal Hormones Today:Glucagon-Like Peptide-1 (GLP-1) and Glucose-ependent Insulinotropic Polypeptide (GIP)

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5,Issue: 3
Page: 176-182
Authors: Malgorzata E. Kiec-Klimczak, Dorota M. Pach, Magdalena E. Pogwizd and Alicja B. Hubalewska-Dydejczyk

Amyloidogenicity and Aggregate Cytotoxicity of Human Glucagon-Like Peptide-1 (hGLP-1)

Journal: Protein & Peptide Letters
Volume: 16,Issue: 12
Page: 1548-1556
Authors: S. Poon, N. R. Birkett, S. B. Fowler, B. F. Luisi, C. M. Dobson and J. Zurdo

Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists

Journal: Current Diabetes Reviews
Volume: 5,Issue: 4
Page: 266-275
Authors: Urd Kielgast, Jens J. Holst and Sten Madsbad

Zinc, Alpha Cells and Glucagon Secretion

Journal: Current Diabetes Reviews
Volume: 6,Issue: 1
Page: 52-57
Authors: Laerke Egefjord, Andreas B. Petersen, Ann M. Bak and Jorgen Rungby

Glucagon-Like Peptide 1 and the Cardiovascular System

Journal: Current Diabetes Reviews
Volume: 10,Issue: 5
Page: 302-310
Authors: Stephen Fava

Glucagon-Like Peptide 2 (GLP-2), An Intestinotrophic Mediator

Journal: Current Protein & Peptide Science
Volume: 5,Issue: 1
Page: 51-65
Authors: J. Thulesen

Cardiovascular Effects of Glucagon-Like Peptide 1

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 1
Page: 97-105
Authors: A. Papazafiropoulou, S. I. Pappas, D. Papadogiannis and N. Tentolouris

Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies

Journal: Current Diabetes Reviews
Volume: 12,Issue: 4
Page: 331-358
Authors: Karen Ekkelund Petersen, Günaj Rakipovski, Kirsten Raun and Jens Lykkesfeldt

Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 22
Page: 2471-2483
Authors: George G. Holz and Oleg G. Chepurny

Glucagon Like Peptides-1 Modulators as Newer Target for Diabetes

Journal: Current Drug Targets
Volume: 9,Issue: 10
Page: 911-920
Authors: H. B. Vaidya and R. K. Goyal

Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 38
Page: 4379-4385
Authors: Sho-ichi Yamagishi and Takanori Matsui

Synthesis and Bioactivity Evaluation of Dipeptidyl Peptidase IV Resistant Glucagon-like Peptide-1 Analogues

Journal: Protein & Peptide Letters
Volume: 17,Issue: 10
Page: 1290-1295
Authors: Jinpei Zhou, Shuaijian Ni, Huibin Zhang, Hai Qian, Yushi Chi, Wenlong Huang, Lu Yu, Xiaowen Hu and Wei Chen

Regulation of Intestinal Chylomicron Production by Glucagon-Like Peptides

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 12,Issue: 2
Page: 92-97
Authors: Joanne Hsieh and Khosrow Adeli

Glucagon Like Peptide-1 (GLP-1) Dynamics Following Bariatric Surgery: A Signpost to a New Frontier

Journal: Current Diabetes Reviews
Volume: 9,Issue: 2
Page: 93-101
Authors: K. J. Neff, D. O’Shea and C. W. le Roux

Male fertility and obesity: are ghrelin, leptin and glucagon-like peptide-1 pharmacologically relevant?

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 7
Page: 783-791
Authors: Marco G. Alves, Tito T. Jesus, Mário Sousa, Erwin Goldberg, Branca M. Silva and Pedro F. Oliveira

Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 29
Page: 3651-3662
Authors: Brian D. Green, Victor A. Gault, Finbarr P.M. O'Harte and Peter R. Flatt

Development of Glucagon-Like Peptide-1-Based Pharmaceuticals as Therapeutic Agents for the Treatment of Diabetes

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 14
Page: 1399-1412
Authors: Daniel J. Drucker

Vascular Protective Effects of Diabetes Medications that Mimic or Increase Glucagon-Like Peptide-1 Activity

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 7,Issue: 1
Page: 2-9
Authors: Angelica J. Motta, Juraj Koska, Peter Reaven and Raymond Q. Migrino

Glucagon-Like Peptide-1 as a Key Regulator of Lipid and Lipoprotein Metabolism in Fasting and Postprandial States

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 14,Issue: 2
Page: 126-136
Authors: Sarah Farr, Jennifer Taher and Khosrow Adeli

Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy

Journal: Current Diabetes Reviews
Volume: 12,Issue: 4
Page: 403-413
Authors: Scott R. Drab

Glucagon-Like Peptide-1-Mediated Modulation of Inflammatory Pathways in the Diabetic Brain: Relevance to Alzheimer’s Disease

Journal: Current Alzheimer Research
Volume: 13,Issue: 12
Page: 1346-1355
Authors: LiMei Qin, Thomas Chong, Richard Rodriguez and Subbiah Pugazhenthi

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome

Journal: Current Vascular Pharmacology
Volume: 15,Issue: 3
Page: 218-229
Authors: Themistoklis Tzotzas, Spyridon N. Karras and Niki Katsiki

Intein-Mediated Expression and Purification of an Analog of Glucagon-like Peptide-1 in Escherichia coli

Journal: Protein & Peptide Letters
Volume: 17,Issue: 10
Page: 1245-1250
Authors: Chen Ma, Mingming Gao, Wenchao Liu, Jing Zhu, Hong Tian, Xiangdong Gao and Wenbing Yao


Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 6
Page: 494-497
Authors: Vasilios G. Athyros, Niki Katsiki and Asterios Karagiannis

The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6,Issue: 1
Page: 27-57
Authors: J. Y.S. Chu, L. T.O. Lee, F. K.Y. Siu and B. K.C. Chow

Allosteric Modulators of Class B G-Protein-Coupled Receptors

Journal: Current Neuropharmacology
Volume: 5,Issue: 3
Page: 168-179
Authors: Sam R.J. Hoare

The Role of Chromogranins and Other Statins in Homeostasis: An Explanation of the Precise Regulation of Glucose and Ionised Calcium in the Blood; An Overview

Journal: Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
Volume: 4,Issue: 3
Page: 235-249
Authors: Johan H. Koeslag and Peter T. Saunders

Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 7
Page: 609-619
Authors: Francisca Araujo, Neha Shrestha, Pedro L. Granja, Jouni Hirvonen, Hélder A. Santos and Bruno Sarmento

Dipeptidyl Peptidase IV Inhibitors: The Next Generation of New Promising Therapies for the Management of Type 2 Diabetes

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 6
Page: 547-555
Authors: Elena Sebokova, Andreas D. Christ, Markus Boehringer and Jacques Mizrahi

Screening of a Phage Display Library of Exendin-4 Mutants with the Extracellular Domain of Rat GLP-1 Receptor

Journal: Protein & Peptide Letters
Volume: 14,Issue: 8
Page: 816-821
Authors: Xiaopu. Yin, Yushu Ma, Meiyun Liu, Weifeng Gao and Dongzhi Wei

Intervention of Hepatic Glucose Production. Small Molecule Regulators of Potential Targets for Type 2 Diabetes Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4,Issue: 8
Page: 897-908
Authors: Tjeerd Barf

Microwave-Assisted Solid Phase Synthesis of GLP-1-Analogues

Journal: Letters in Organic Chemistry
Volume: 5,Issue: 5
Page: 399-402
Authors: Yushi Chi, Huibin Zhang, Jinpei Zhou, Wenlong Huang and Shuaijian Ni

Liraglutide-A Novel GLP-1 Analogue

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 3,Issue: 3
Page: 200-204
Authors: Sanjay Kalra, Bharti Kalra and Amit Sharma

Computational Identification of Inhibitors Against DPP-IV for Checking Type-2 Diabetes

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 1
Page: 66-73
Authors: Sarvesh Kumar Gupta, Kamal Kumar Chaudhary, Utkarsh Raj and Nidhi Mishra

Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes

Journal: Current Drug Targets
Volume: 10,Issue: 1
Page: 71-87
Authors: Rajesh Gupta, Sameer S. Walunj, Ranjeet K. Tokala, Kishore V.L. Parsa, Santosh Kumar Singh and Manojit Pal

Progress in the Oral Treatment of Type 2 Diabetes: Update on DPP-IV Inhibitors

Journal: Current Diabetes Reviews
Volume: 5,Issue: 2
Page: 92-101
Authors: Teresa Salvatore, Ornella Carbonara, Domenico Cozzolino, Roberto Torella and Ferdinando C. Sasso

Neural Pathways and Neuropeptides Mediate the Therapeutic Actions of DPP IV Inhibitors in Type-2 Diabetes

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 1,Issue: 2
Page: 132-135
Authors: Adnan Erol

An Update in Incretin-Based Therapy: A Focus on Dipeptidyl Peptidase - 4 Inhibitors

Journal: Current Diabetes Reviews
Volume: 8,Issue: 3
Page: 169-182
Authors: Brian K. Irons, Jessica M. Weis, Megan R. Stapleton and Krystal L. Edwards

Anti-Diabetic Compounds and their Patent Information: An Update

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 7,Issue: 1
Page: 35-48
Authors: Rajesh Pandey, Narendra Kumar, Mukesh Yadav, Ravinder Nagpal, Shalini Jain and Hariom Yadav

Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment

Journal: Current Drug Targets
Volume: 15,Issue: 6
Page: 600-621
Authors: Sridhara Janardhan and G. Narahari Sastry

Adapting the GLP-1-Signaling System to the Treatment of Type 2 Diabetes

Journal: Current Diabetes Reviews
Volume: 3,Issue: 1
Page: 15-23
Authors: Teresa Salvatore, Ornella Carbonara, Domenico Cozzolino, Roberto Torella and Ferdinando Carlo Sasso

Diabetic Medications in Pregnancy

Journal: Current Diabetes Reviews
Volume: 5,Issue: 4
Page: 252-258
Authors: James Young and Aresh Anwar

Pharmacological Management of Type 2 Diabetes Mellitus: An Update

Journal: Current Diabetes Reviews
Volume: 7,Issue: 6
Page: 392-405
Authors: Samer El-Kaissi and Suphia Sherbeeni

Recent Advances in the Development of Nonpeptide Somatostatin Receptor Ligands

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 2,Issue: 5
Page: 507-517
Authors: A. Michael Crider

Biological Active Peptides from Marine Sources Related to Gut Hormones

Journal: Current Protein & Peptide Science
Volume: 14,Issue: 3
Page: 231-234
Authors: Benoit Cudennec and Rozenn Ravallec

Incretin Based Therapies: Bone Protective Effects

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 13,Issue: 4
Page: 289-294
Authors: Marlene Chakhtoura and Sami T. Azar

Passage of VIP / PACAP / Secretin Family Across the Blood-Brain Barrier: Therapeutic Effects

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 12
Page: 1325-1340
Authors: Dilek Dogrukol-Ak, Fatma Tore and Nese Tuncel

Incretin-Based Therapy of Type 2 Diabetes Mellitus

Journal: Current Protein & Peptide Science
Volume: 10,Issue: 1
Page: 46-55
Authors: Filip K. Knop, Tina Vilsboll and Jens J. Holst

GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy

Journal: Current Clinical Pharmacology
Volume: 7,Issue: 3
Page: 214-228
Authors: Giuseppe Derosa and Pamela Maffioli

Insulin Regulation of PEPCK Gene Expression: A Model for Rapid and Reversible Modulation

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 5,Issue: 4
Page: 423-437
Authors: P. G. Quinn and D. Yeagley

Novel Peptides under Development for the Treatment of Type 1 and Type 2 Diabetes Mellitus

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 2,Issue: 1
Page: 63-82
Authors: Alain D. Baron, Dennis Kimm and Christian Weyer

PACAP in the Glucose and Energy Homeostasis: Physiological Role and Therapeutic Potential

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 11
Page: 1105-1112
Authors: Masanori Nakata and Toshihiko Yada

PACAP in Avians: Origin, Occurrence, and Receptors - Pharmacological and Functional Considerations

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 6
Page: 467-481
Authors: Jerzy Z. Nowak and Jolanta B. Zawilska

Potential Drug Targets and Progress Towards Pharmacologic Inhibition of Hepatic Glucose Production

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 2
Page: 123-153
Authors: R. Kurukulasuriya, J. T. Link, D. J. Madar, Z. Pei, S. J. Richards, J. J. Rohde, A. J. Souers and B. G. Szczepankiewicz

Adiposity and the Gut - The Role of Gut Hormones

Journal: Current Nutrition & Food Science
Volume: 3,Issue: 1
Page: 75-90
Authors: Vian Amber and Stephen R. Bloom

GLP-1 Agonists and Satiety

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 8,Issue: 4
Page: 311-316
Authors: Nicholas T. Bello and Timothy H. Moran

Oral Protein Delivery: A Patent Review of Academic and Industrial Approaches

Journal: Recent Patents on Drug Delivery & Formulation
Volume: 3,Issue: 2
Page: 94-104
Authors: Martin Werle, Abdallah Makhlof and Hirofumi Takeuchi

Bioartificial Pancreas: Drug Delivery through Islet Microencapsulation to Treat Diabetes

Journal: Recent Patents on Biomedical Engineering (Discontinued)
Volume: 5,Issue: 1
Page: 41-50
Authors: Rajesh A. Pareta

Geniposide Regulates Insulin-Degrading Enzyme Expression to Inhibit the Cytotoxicity of Aβ1-42 in Cortical Neurons

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 8
Page: 1045-1051
Authors: Fei Yin, Yonglan Zhang, Lixia Guo, Shuzhen Kong and Jianhui Liu

Treatment of Insulin Resistance in the Neurodegeneration

Journal: Recent Patents on CNS Drug Discovery
Volume: 9,Issue: 1
Page: 54-63
Authors: Manuela Stefanelli, Antonio Martocchia, Elisabetta Adele De Marinis, Giulia Maria Falaschi, Gloria Romano, Maddalena Rufo and Paolo Falaschi

Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development

Journal: Current Diabetes Reviews
Volume: 11,Issue: 1
Page: 17-31
Authors: Friedrich Mittermayer, Erica Caveney, Claudia De Oliveira, Loukas Gourgiotis, Mala Puri, Li-Jung Tai and J. Rick Turner

Recent Advances in Synthetic Chemistry of Diabetic Research

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15,Issue: 14
Page: 1159-1163
Authors: Sreekanth Thota and Carlos M. Morel

Evaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis

Journal: Current Radiopharmaceuticals
Volume: 10,Issue: 1
Page: 65-72
Authors: Bluma Linkowski Faintuch, Daniele Seo, Erica Aparecida de Oliveira, Roselaine Campos Targino and Ana Maria Moro

Sympathetic Mechanisms of Hypoglycemic Counterregulation

Journal: Current Diabetes Reviews
Volume: 3,Issue: 3
Page: 185-193
Authors: Robert P. Hoffman

Inhibition of Dipeptidyl Peptidase-4 (DPP-4) - A Novel Approach to Treat Type 2 Diabetes

Journal: Current Enzyme Inhibition
Volume: 1,Issue: 1
Page: 65-73
Authors: Bo Ahren

Peptidomics Biomarker Discovery in Mouse Models of Obesity and Type 2 Diabetes

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 8,Issue: 8
Page: 775-781
Authors: Petra Budde, Imke Schulte, Annette Appel, Susanne Neitz, Markus Kellmann, Harald Tammen, Rudiger Hess and Horst Rose

Central Pre-proglucagon Derived Peptides: Opportunities for Treatment of Obesity

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 17
Page: 1373-1382
Authors: Philip J. Larsen, Niels Vrang and Mads Tang-Christensen

The Family B1 GPCR: Structural Aspects and Interaction with Accessory Proteins

Journal: Current Drug Targets
Volume: 13,Issue: 1
Page: 103-115
Authors: Alain Couvineau and Marc Laburthe

Current Advances and Therapeutic Potential of Agents Targeting Dipeptidyl Peptidases-IV, -II, 8/9 and Fibroblast Activation Protein

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 12
Page: 1447-1463
Authors: Shu-Jen Chen and Weir-Torn Jiaang

GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes

Journal: Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
Volume: 5,Issue: 6
Page: 485-497
Authors: Juris J. Meier and Michael A. Nauck

Inhibition of Dipeptidyl Peptidase-4 (DPP-4): A Target to Treat Type 2 Diabetes

Journal: Current Enzyme Inhibition
Volume: 7,Issue: 4
Page: 205-217
Authors: Bo Ahren

Evolution of Exenatide as a Diabetes Therapeutic

Journal: Current Diabetes Reviews
Volume: 9,Issue: 2
Page: 161-193
Authors: Sunil Bhavsar, Sunder Mudaliar and Alan Cherrington

Incretin-Based Therapies, Glucometabolic Health and Endovascular Inflammation

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 31
Page: 4953-4960
Authors: Manfredi Rizzo, Dragana Nikolic, Maciej Banach, Angelo Maria Patti, Giuseppe Montalto and Ali A. Rizvi

Expression of CTB-10×rolGLP-1 in E.coli and Its Therapeutic Effect on Type 2 Diabetes

Journal: Current Pharmaceutical Biotechnology
Volume: 16,Issue: 6
Page: 564-572
Authors: Peipei Tu, Zhihua Ma, Haisong Wang, Baicheng Ma, Xiaodan Li, Huikun Duan, Pingzhe Jiang, Miao Li, Ri Wu, Jianhong Zhu and Minggang Li

GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 36
Page: 5292-5298
Authors: Djordje S. Popovic, Edita Stokic and Stevan L. Popovic

G Protein-Coupled Receptors in Regulation of Body Weight

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 3
Page: 241-249
Authors: Helgi B. Schioth

A False Paradise - Mixed Blessings in the Protein Universe: The Amyloid as a New Challenge in Drug Development

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 11
Page: 1221-1230
Authors: Ludmilla Morozova-Roche and Mantas Malisauskas

Emerging Therapies for Type 2 Diabetes

Journal: Current Drug Therapy
Volume: 2,Issue: 2
Page: 151-160
Authors: Anthony H. Stonehouse and David G. Maggs

The Therapeutic Potential of Inhibitors of Dipeptidyl Peptidase IV (DPP IV) and Related Proline-Specific Dipeptidyl Aminopeptidases

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 8
Page: 971-998
Authors: K. Augustyns, P. Van der Veken, K. Senten and A. Haemers

The Hypothalamus and Obesity

Journal: Current Drug Targets
Volume: 6,Issue: 2
Page: 225-240
Authors: Peter J. King

Pharmacological Approaches to Inhibit Endogenous Glucose Production as a Means of Anti-diabetic Therapy

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 14
Page: 1451-1474
Authors: James G. McCormack, Niels Westergaard, Marit Kristiansen, Christian L. Brand and Jesper Lau

Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors

Journal: Current Diabetes Reviews
Volume: 4,Issue: 2
Page: 101-109
Authors: Anthony Stonehouse, Ted Okerson, David Kendall and David Maggs

Recent Advances in Antidiabetic Drug Therapies Targeting the Enteroinsular Axis

Journal: Current Drug Metabolism
Volume: 10,Issue: 2
Page: 125-137
Authors: P. R. Flatt, C. J. Bailey and B. D. Green

The Metabolic Approach in Patients with Heart Failure: Effects on Left Ventricle Remodeling

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 8
Page: 850-856
Authors: W.H. Wilson Tang

Appraisal of Saxagliptin as Treatment of Type 2 Diabetes

Journal: Current Drug Therapy
Volume: 5,Issue: 2
Page: 111-117
Authors: Nasser Mikhail and Dennis Cope

New and Emerging Antiresorptive Treatments in Osteoporosis

Journal: Current Drug Safety
Volume: 6,Issue: 2
Page: 75-88
Authors: Lars Rejnmark and Leif Mosekilde

Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers Disease

Journal: Recent Patents on CNS Drug Discovery
Volume: 5,Issue: 2
Page: 109-117
Authors: Christian Holscher

Interaction between Gastric and Upper Small Intestinal Hormones in the Regulation of Hunger and Satiety: Ghrelin and Cholecystokinin Take the Central Stage

Journal: Current Protein & Peptide Science
Volume: 12,Issue: 4
Page: 293-304
Authors: Andreas Stengel and Yvette Tache

Dipeptidyl Peptidase-IV Inhibitors: An Evolving Treatment for Type 2 Diabetes from the Incretin Concept

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 1,Issue: 1
Page: 15-24
Authors: Yau-Jan Chyan and Lee-Ming Chuang

Incretins and Preservation of Endothelial Function

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10,Issue: 4
Page: 295-308
Authors: Juraj Koska

Cardiac Protection via Metabolic Modulation: An Emerging Role for Incretin-Based Therapies?

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10,Issue: 4
Page: 319-324
Authors: Liam M. McCormick, Anna C. Kydd and David P. Dutka

The Effects of Incretins on Energy Homeostasis: Physiology and Implications for the Treatment of Type 2 Diabetes Mellitus and Obesity

Journal: Current Vascular Pharmacology
Volume: 10,Issue: 6
Page: 781-791
Authors: Spyridon Karras, Dimitrios G. Goulis, Gesthimani Mintziori, Niki Katsiki and Themistoklis Tzotzas

A Diabetes Treatment Strategy to Reduce the Risk of Cardiovascular Events: Clinical Benefits and Potential of Linagliptin

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 81-88
Authors: Ryuichi Morishita and Sho-ichi Yamagishi

Duodenal Luminal Chemosensing; Acid, ATP, and Nutrients

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 16
Page: 2760-2765
Authors: Yasutada Akiba and Jonathan D. Kaunitz

The Sense of Taste in the Upper Gastrointestinal Tract

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 16
Page: 2713-2724
Authors: Akihiko Kitamura, Tomokazu Tsurugizawa, Akira Uematsu and Hisayuki Uneyama

The Role of Oral Antidiabetic Agents and Incretin Mimetics in Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 22
Page: 3705-3715
Authors: Ioanna Gouni-Berthold, Nikolaos Papanas and Efstratios Maltezos

Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 2
Page: 271-282
Authors: Ying Dai and Mohammad A. Kamal

CD26: A Multi-Purpose Pharmacological Target

Journal: Current Clinical Pharmacology
Volume: 9,Issue: 2
Page: 157-164
Authors: Formica Vincenzo, Tesauro Manfredi, Cardillo Carmine and Roselli Mario

Development of Pyrazole Compounds as Antidiabetic Agent: A Review

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 5
Page: 686-703
Authors: Prasanna A. Datar and Sonali R. Jadhav

The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease

Journal: Current Diabetes Reviews
Volume: 11,Issue: 3
Page: 191-200
Authors: V. Agrawal, C. Giri and R. J. Solomon

Novel Therapeutic Targets for Management of Type-2 Diabetes Mellitus

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 16,Issue: 1
Page: 18-30
Authors: Anishkumar Chaurasia, Rashmi Mallya and Tabassum Khan

Incretins, Pregnancy, and Gestational Diabetes

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 7
Page: 597-602
Authors: Dragana Nikolic, Khalid Al-Rasadi, Noor Al Busaidi, Khalid Al-Waili, Yajnavalka Banerjee, Khamis Al-Hashmi, Giuseppe Montalto, Ali A. Rizvi, Manfredi Rizzo and Tamima Al-Dughaishi

GPR 120: The Potential Target for Obesity Treatment

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 16,Issue: 1
Page: 8-11
Authors: Peter A. Tanagho and Kyrillus S. Shohdy

SGLT2 Inhibitors in Diabetes Mellitus Treatment

Journal: Reviews on Recent Clinical Trials
Volume: 12,Issue: 1
Page: 8-18
Authors: Juan Rosas-Guzman, Juan Rosas-Saucedo and Alma R.J. Romero-Garcia

After 10 Years of Clinical Trials with Liraglutide in Diabetes, What do we Know About its Effects on Clinical Cardiovascular Outcomes?

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 1
Page: 68-77
Authors: Sheila A. Doggrell

Investigation of Exenatide Elimination and Its In Vivo and In Vitro Degradation

Journal: Current Drug Metabolism
Volume: 7,Issue: 4
Page: 367-374
Authors: Kathrin Copley, Kevin McCowen, Richard Hiles, Loretta L. Nielsen, Andrew Young and David G. Parkes

Role of Opioid Antagonists in the Treatment of Women with Glucoregulation Abnormalities

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 8
Page: 1001-1012
Authors: M. Guido, D. Romualdi and A. Lanzone

Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 11
Page: 1113-1139
Authors: Elena Gonzalez-Rey, Nieves Varela, Alejo Chorny and Mario Delgado

Pancreatic Amylin as a Centrally Acting Satiating Hormone

Journal: Current Drug Targets
Volume: 6,Issue: 2
Page: 181-189
Authors: Thomas A. Lutz

The Pharmacology of Human Appetite Expression

Journal: Current Drug Targets
Volume: 5,Issue: 3
Page: 221-240
Authors: Jason C.G. Halford, Gillian D. Cooper and Terence M. Dovey

A New Alzheimers Disease Interventive Strategy: GLP-1

Journal: Current Drug Targets
Volume: 5,Issue: 6
Page: 565-571
Authors: Tracy Ann Perry and Nigel H. Greig

The FRK / RAK-SHB Signaling Cascade: A Versatile Signal- Transduction Pathway that Regulates Cell Survival, Differentiation and Proliferation

Journal: Current Molecular Medicine
Volume: 3,Issue: 4
Page: 313-324
Authors: Cecilia Anneren, Cecilia K. Lindholm, Vitezslav Kriz and Michael Welsh

Roles of Growth Factors in Chemotherapy-Induced Intestinal Mucosal Damage Repair

Journal: Current Pharmaceutical Biotechnology
Volume: 4,Issue: 4
Page: 260-269
Authors: C. J. Xian

Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 14
Page: 1353-1373
Authors: C. Weyer, D. G. Maggs, A. A. Young and O. G. Kolterman

Targeted Tumor Diagnosis and Therapy with Peptide Hormones as Radiopharmaceuticals

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 2
Page: 186-199
Authors: Annette G. Beck-Sickinger and Irfan Ullah Khan

How Insulin Receptor Substrate Proteins Regulate the Metabolic Capacity of the Liver - Implications for Health and Disease

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 13
Page: 1316-1329
Authors: Louise Fritsche, Cora Weigert, Hans-Ulrich Haring and Rainer Lehmann

WNT Signaling in Stem Cell Biology and Regenerative Medicine

Journal: Current Drug Targets
Volume: 9,Issue: 7
Page: 565-570
Authors: Masaru Katoh

The Effects of Medications Used for the Management of Diabetes and Obesity on Postprandial Lipid Metabolism

Journal: Current Diabetes Reviews
Volume: 4,Issue: 4
Page: 340-356
Authors: Ioanna Eleftheriadou, Pinelopi Grigoropoulou, Nicholas Katsilambros and Nicholas Tentolouris

Current Status and Perspectives in Peptide Receptor Radiation Therapy

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 21
Page: 2453-2462
Authors: Catherine Ansquer, Francoise Kraeber-Bodere and Jean Francoise Chatal

Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 23
Page: 2943-2951
Authors: E. Matteucci and O. Giampietro

Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 31
Page: 3644-3655
Authors: A. Fernandez-Gamba, M. C. Leal, L. Morelli and E. M. Castano

Production of Pancreatic Beta-Cells from Stem Cells

Journal: Current Diabetes Reviews
Volume: 6,Issue: 3
Page: 184-190
Authors: Hirofumi Noguchi

Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes

Journal: Current Diabetes Reviews
Volume: 6,Issue: 4
Page: 191-200
Authors: Danilo Verge and Ximena Lopez

Novel and Current Treatment Concepts Using Pulmonary Drug Delivery

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 22
Page: 2484-2492
Authors: Martin Hohenegger

Alogliptin: a Novel Molecule for Improving Glycemic Control in Type II Diabetes Mellitus

Journal: Current Diabetes Reviews
Volume: 6,Issue: 6
Page: 410-421
Authors: Somsuvra B. Ghatak, Devang S. Patel, Neeraj Shanker, Ambrish Srivastava, Shrikalp S. Deshpand and Shital J. Panchal

Linagliptin: A Novel Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor for Treatment of Type II Diabetes Mellitus

Journal: Current Diabetes Reviews
Volume: 7,Issue: 5
Page: 325-335
Authors: Somsuvra B. Ghatak, Devang S. Patel, Neeraj Shanker, Ambrish Srivastava, Shrikalp S. Deshpande and Shital J. Panchal

Signalling Satiety and Starvation to β-Cell Insulin Secretion

Journal: Current Diabetes Reviews
Volume: 7,Issue: 5
Page: 336-345
Authors: Mark J. Holness, Sharif Hegazy and Mary C. Sugden

Is Exenatide Improving the Treatment of Type 2 Diabetes? Analysis of the Individual Clinical Trials with Exenatide

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 1
Page: 77-84
Authors: Sheila A. Doggrell

New Horizons in Diabetes Therapy

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 49-55
Authors: Jens Juul Holst and Carolyn F. Deacon

Discovery of JANUVIA TM (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type2 Diabetes.

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 6
Page: 557-568
Authors: Nancy A. Thornberry and Ann E. Weber

Enhancing Central Nervous System Endogenous GLP-1 Receptor Pathways for Intervention in Alzheimers Disease

Journal: Current Alzheimer Research
Volume: 2,Issue: 3
Page: 377-385
Authors: TracyAnn Perry and Nigel H. Greig

The Physiology of Learning and Memory: Role of Peptides and Stress

Journal: Current Protein & Peptide Science
Volume: 5,Issue: 6
Page: 457-473
Authors: M. A. Gulpinar and B. C. Yegen

PACAP and Its Receptors Exert Pleiotropic Effects in The Nervous System by Activating Multiple Signaling Pathways

Journal: Current Protein & Peptide Science
Volume: 3,Issue: 4
Page: 423-439
Authors: Cheng-Ji Zhou, Seiji Shioda, Toshihiko Yada, Nobuya Inagaki, Samuel J. Pleasure and Sakae Kikuyama

Metabolic Regulation and Behavior: How Hunger Produces Arousal - An Insect Study

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 7,Issue: 4
Page: 304-310
Authors: Dieter Wicher

Physiology of Islet Engraftment

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 6,Issue: 2
Page: 167-178
Authors: C. Kampf and P-O. Carlsson

Stability and Bioactivity Studies on Dipeptidyl Peptidase IV Resistant Glucogan-like Peptide-1 Analogues

Journal: Protein & Peptide Letters
Volume: 19,Issue: 2
Page: 203-211
Authors: Wei Chen, Yinghong Zhou, Huibin Zhang, Hai Qian, Wenlong Huang, Baowei Yang, Jing Han, Jingpei Zhou, Yushi Chi and Shuaijian Ni

Gut Hormones as Peripheral Anti Obesity Targets

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 3,Issue: 5
Page: 379-388
Authors: Caroline J. Small and Stephen R. Bloom

Cellular Localisation of Chromogranins and Processed Products in the Diffuse Neuroendocrine System and Related Tumours

Journal: Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
Volume: 4,Issue: 3
Page: 149-160
Authors: Mats Stridsberg, Eva T. Janson and Guida M. Portela-Gomes

Neuroendocrine Targets for the Treatment of Obesity: Physiological Roles and Unrealized Opportunities

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 3,Issue: 3
Page: 141-155
Authors: J. A. Harrold, G. Williams and S. Wong

Physiological and Pharmacological Regulation of Hepatic 3-Hydroxy-3- Methylglutaryl Coenzyme A Reductase

Journal: Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
Volume: 3,Issue: 3
Page: 219-227
Authors: Gene C. Ness

Roles and Regulation of the Transcription Factor CREB in Pancreatic β -Cells

Journal: Current Molecular Pharmacology
Volume: 4,Issue: 3
Page: 187-195
Authors: Stephane Dalle, Julie Quoyer, Elodie Varin and Safia Costes

Pharmacotherapy in Type 2 Diabetes: A Functional Schema for Drug Classification

Journal: Current Diabetes Reviews
Volume: 8,Issue: 4
Page: 257-267
Authors: Janet B. McGill

Novel Target Identification Technologies for the Personalised Therapy of Type II Diabetes and Obesity

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 12,Issue: 3
Page: 183-207
Authors: Gunter Muller

Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes

Journal: Current Diabetes Reviews
Volume: 9,Issue: 1
Page: 25-53
Authors: Zhuo Fu, Elizabeth R. Gilbert and Dongmin Liu

The Central Nervous System as a Promising Target to Treat Diabetes Mellitus

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 19
Page: 2070-2081
Authors: Jose Donato Jr.

The Science of Hypoglycemia in Patients with Diabetes

Journal: Current Diabetes Reviews
Volume: 9,Issue: 3
Page: 195-208
Authors: David S. Oyer

Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review

Journal: Current Vascular Pharmacology
Volume: 11,Issue: 6
Page: 992-1000
Authors: Evangelos C. Rizos, Evangelia E. Ntzani, Nikolaos Papanas, Vasilis Tsimihodimos, Zoi Mitrogianni, Efstratios Maltezos and Moses S. Elisaf

Free Fatty Acids-Sensing G Protein-Coupled Receptors in Drug Targeting and Therapeutics

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 31
Page: 3855-3871
Authors: Tomo Yonezawa, Riho Kurata, Kaori Yoshida, Masanori A. Murayama, Xiaofeng Cui and Akihiko Hasegawa

Peptide-based Radiopharmaceuticals for Targeted Tumor Therapy

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 1
Page: 139-152
Authors: C. Dong, Z. Liu and F. Wang

Emerging Roles for Vasoactive Peptides in Diagnostic and Therapeutic Strategies Against Atherosclerotic Cardiovascular Diseases

Journal: Current Protein & Peptide Science
Volume: 14,Issue: 6
Page: 472-480
Authors: Takuya Watanabe, Kengo Sato, Fumiko Itoh, Yuri Noguchi, Kazumi Fujimoto, Takatoshi Koyama and Masayoshi Shichiri

MK-0626, A Dipeptidyl Peptidase-4 Inhibitor, Improves Neovascularization by Increasing Both the Number of Circulating Endothelial Progenitor Cells and Endothelial Nitric Oxide Synthetase Expression

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 17
Page: 2012-2022
Authors: Chun-Ming Shih, Yung-Hsiang Chen, Yi-Wen -Lin, Nai-Wen Tsao, Shinn-Chih Wu, Yung-Ta Kao, Kuang-Hsing Chiang, Chi-Yuan Li, Nen-Chung Chang, Cheng-Yen Lin, Chun-Yao Huang and Feng-Yen Lin

Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 3
Page: 418-428
Authors: Marcelo M.S. Lima, Adriano D.S. Targa, Ana C.D. Noseda, Lais S. Rodrigues, Ana Marcia Delattre, Fabiola V. dos Santos, Mariana H. Fortes, Maira J. Maturana and Anete C. Ferraz

Expression and Purification of Optimized rolGLP-1, A Novel GLP-1 Analog, in Escherichia Coli BL21(DE3) and its Good Glucoregulatory Effect on Type 2 Diabetic Mice

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 11
Page: 985-994
Authors: Baicheng Ma, Peipei Tu, Xingyu Zhao, Yaofang Zhang, Yu Wang, Chao Ma, Yanli Ji, Xiaodan Li, Syed A. Abbas and Minggang Li

Assessment of Pancreatic β-Cell Function: Review of Methods and Clinical Applications

Journal: Current Diabetes Reviews
Volume: 10,Issue: 1
Page: 2-42
Authors: Eugenio Cersosimo, Carolina Solis-Herrera, Michael E. Trautmann, Jaret Malloy and Curtis L. Triplitt

Cardiovascular Effects of Current and Future Anti-Obesity Drugs

Journal: Current Vascular Pharmacology
Volume: 12,Issue: 3
Page: 493-504
Authors: Simon Comerma-Steffensen, Martin Grann, Charlotte U. Andersen, Jorgen Rungby and Ulf Simonsen

Bariatric Surgery - Effects on Obesity and Related co-Morbidities

Journal: Current Diabetes Reviews
Volume: 10,Issue: 3
Page: 208-214
Authors: Maria Saur Svane and Sten Madsbad

Effect of GLP-1 Based Therapies on Diabetic Dyslipidemia

Journal: Current Diabetes Reviews
Volume: 10,Issue: 4
Page: 238-250
Authors: Vishal J. Patel, Amit A. Joharapurkar, Gaurang B. Shah and Mukul R. Jain

Procyanidins and Their Healthy Protective Effects Against Type 2 Diabetes

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 1
Page: 39-50
Authors: Noemi Gonzalez-Abuin, Montserrat Pinent, Angela Casanova-Marti, Lluis Arola, Mayte Blay and Anna Ardevol

Physiological Mechanisms of Action of Incretin and Insulin in Regulating Skeletal Muscle Metabolism

Journal: Current Diabetes Reviews
Volume: 10,Issue: 5
Page: 327-335
Authors: Haitham Abdulla, Bethan Phillips, Kenneth Smith, Daniel Wilkinson, Philip J. Atherton and Iskandar Idris

Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 10
Page: 1819-1835
Authors: Andre F. Carvalho, Kamilla K. Miskowiak, Thomas N. Hyphantis, Cristiano A. Kohler, Gilberto S. Alves, Beatrice Bortolato, Paulo Marcelo G. Sales, Rodrigo Machado-Vieira, Michael Berk and Roger S. McIntyre

Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 10
Page: 1693-1707
Authors: Celina S. Liu, Andre F. Carvalho and Roger S. McIntyre

Cell Signaling Mechanisms by which Geniposide Regulates Insulin- Degrading Enzyme Expression in Primary Cortical Neurons

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 3
Page: 370-377
Authors: Yonglan Zhang, Zhining Xia, Jianhui Liu and Fei Yin

How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 10
Page: 1242-1259
Authors: Robert Root-Bernstein

Beta Cell Formation in vivo Through Cellular Networking, Integration and Processing (CNIP) in Wild Type Adult Mice

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 4
Page: 376-388
Authors: Bruno Doiron, Wenchao Hu and Ralph A DeFronzo

Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 7
Page: 667-685
Authors: Gergő A. Molnár, Szilárd Kun, Eszter Sélley, Melinda Kertész, Lívia Szélig, Csaba Csontos, Katalin Böddi, Lajos Bogár, Attila Miseta and István Wittmann

Novel Methods of Insulin Replacement: The Artificial Pancreas and Encapsulated Islets

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 2
Page: 106-123
Authors: Rana Malek and Stephen N. Davis

Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?

Journal: Current Drug Targets
Volume: 17,Issue: 11
Page: 1252-1264
Authors: Karly C. Sourris, Henry Yao, George Jerums, Mark E.Cooper, Elif I. Ekinci and Melinda T. Coughlan

Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 36
Page: 5572-5587
Authors: Basak Ozgen Saydam and Bulent O. Yildiz

Gut-Brain Axis in Gastric Mucosal Damage and Protection

Journal: Current Neuropharmacology
Volume: 14,Issue: 8
Page: 959-966
Authors: Dolores Sgambato, Annalisa Capuano, Maria Giuseppa Sullo, Agnese Miranda, Alessandro Federico and Marco Romano

Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 37
Page: 4231-4259
Authors: John Rafferty, Hema Nagaraj, Alice P. McCloskey, Rawan Huwaitat, Simon Porter, Alyaa Albadr and Garry Laverty

The Psychopharmacology of Appetite: Targets for Potential Anti-Obesity Agents

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 3,Issue: 4
Page: 283-310
Authors: Jason C.G. Halford, Gillian D. Cooper, Terence M. Dovey, Yuko Ishii, John Rodgers and John E. Blundell

p38 MAP Kinase Interacts with and Stabilizes Pancreatic and Duodenal Homeobox-1

Journal: Current Molecular Medicine
Volume: 13,Issue: 3
Page: 377-386
Authors: G. Zhou, H. Wang, S.-H. Liu, K. M. Shahi, X. Lin, J. Wu, X.-H. Feng, J. Qin, T.-H. Tan and F. C. Brunicardi

Short and Long Term Effects of a DPP-4 Inhibitor Versus Bedtime NPH Insulin as ADD-ON Therapy in Patients with Type 2 Diabetes

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 44
Page: 6716-6721
Authors: Giordana Maluf da Silva, Katia Camarano Nogueira, Rosa Tsuneshiro Fukui, Marcia Regina Soares Correia, Rosa Ferreira dos Santos and Maria Elizabeth Rossi da Silva

Editorial (Thematic Issue: Frontiers in Atherosclerosis, Heart Disease and Diabetes)

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 14,Issue: 2
Page: 87-88
Authors: Zemin Yao

Editorial (Thematic Issue: Nanotechnology as a Strategy to Improve Treatment of Diabetes)

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 7
Page: 589-589
Authors: Antonio J. Ribeiro

Results 1 - 185 of 185